Beyond the glucose curve: Following cats on SGLT2 inhibitors

Kelly Cairns，DVM、MS、DACVIM (SAIM)，解释了安全性和患者选择如何影响糖尿病猫开始口服 SGLT2 抑制剂的决定，以及哪些患者是强有力的候选者。 She also shares why the monitoring plan looks different than it does with insulin, and what that distinction means for primary care teams. Below is a partial transcript of the conversation. dvm360: When you first see a newly diabetic cat, how do you decide between insulin or SGLT2 drugs? Kelly Cairns，DVM、MS、DACVIM (SAIM)：对我来说，这个决定实际上是基于安全和患者选择，而不是考虑口服药物是否会更容易让客户给那只猫服用，所以我心里有非常清晰的界限。我们有两种很棒的药物：Bexacat [贝格列净] 和 Senvelgo [velagliflozin 口服溶液]。 There’s a liquid, there is a tablet.对于曾经接受过胰岛素、现在正在接受胰岛素或患有胰岛素依赖性糖尿病的猫来说，它们是禁忌的。我们不应该让猫停止使用胰岛素而只给它们服用 SGLT2 抑制剂。 I also do not use the oral drug if a cat is sick at the moment—clinically anorectic, dehydrated, lethargic, or ketotic.如果